Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

Catriona Yale Biography and Net Worth

Insider of Akero Therapeutics

Kitty Yale is Chief Development Officer of Akero Therapeutics. Kitty joins Akero from Gilead Sciences, where she led global clinical operations and management of the company’s oncology, HIV, inflammation, and liver disease trials, and held senior clinical research and operations roles at Gilead and Roche Global Development. As VP of Clinical Operations at Gilead, her most recent role prior to joining Akero, Kitty led global development programs resulting in eight drug approvals in the US, EMEA, Canada, Korea, Japan, and China.

What is Catriona Yale's net worth?: The estimated net worth of Catriona Yale is at least $2.27 million as of November 15th, 2024. Ms. Yale owns 74,158 shares of Akero Therapeutics stock worth more than $2,272,201 as of November 20th. This net worth evaluation does not reflect any other investments that Ms. Yale may own. Additionally, Ms. Yale receives an annual salary of $678,060.00 as Insider at Akero Therapeutics. Learn More about Catriona Yale's net worth.
How old is Catriona Yale?: Ms. Yale is currently 52 years old. There are 7 older executives and no younger executives at Akero Therapeutics. The oldest executive at Akero Therapeutics is Dr. Timothy Rolph, Co-Founder & Chief Scientific Officer, who is 70 years old. Learn More on Catriona Yale's age.
What is Catriona Yale's salary?: As the Insider of Akero Therapeutics, Inc., Ms. Yale earns $678,060.00 per year. There are 2 executives that earn more than Ms. Yale. The highest earning executive at Akero Therapeutics is Dr. Andrew Cheng M.D., Ph.D., President, CEO & Director, who commands a salary of $1,040,000.00 per year. Learn More on Catriona Yale's salary.
How do I contact Catriona Yale?: The corporate mailing address for Ms. Yale and other Akero Therapeutics executives is 170 HARBOR WAY, SOUTH SAN FRANCISCO CA, 94080. Akero Therapeutics can also be reached via phone at (650) 487-6488 and via email at [email protected]. Learn More on Catriona Yale's contact information.
Has Catriona Yale been buying or selling shares of Akero Therapeutics?: In the last ninety days, Catriona Yale has sold $1,087,519.26 in Akero Therapeutics stock. Most recently, Catriona Yale sold 9,061 shares of the business's stock in a transaction on Friday, November 15th. The shares were sold at an average price of $27.73, for a transaction totalling $251,261.53. Following the completion of the sale, the insider now directly owns 74,158 shares of the company's stock, valued at $2,056,401.34. Learn More on Catriona Yale's trading history.
Who are Akero Therapeutics' active insiders?: Akero Therapeutics' insider roster includes Kevin Bitterman (Director), Andrew Cheng (CEO), William White (CFO), Catriona Yale (Insider), and Jonathan Young (COO). Learn More on Akero Therapeutics' active insiders.
Are insiders buying or selling shares of Akero Therapeutics?: During the last twelve months, Akero Therapeutics insiders bought shares 2 times. They purchased a total of 150,000 shares worth more than $2,828,000.00. During the last twelve months, insiders at the sold shares 41 times. They sold a total of 777,704 shares worth more than $22,728,155.84. The most recent insider tranaction occured on November, 15th when insider Catriona Yale sold 9,061 shares worth more than $251,261.53. Insiders at Akero Therapeutics own 7.9% of the company. Learn More about insider trades at Akero Therapeutics.
Information on this page was last updated on 11/15/2024.

Catriona Yale Insider Trading History at Akero Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/15/2024	Sell	9,061	$27.73	$251,261.53	74,158
11/1/2024	Sell	15,485	$32.62	$505,120.70	74,158
10/30/2024	Sell	4,515	$32.53	$146,872.95	74,158
10/14/2024	Sell	6,136	$30.03	$184,264.08	74,158
9/20/2024	Sell	5,500	$27.65	$152,075.00	75,294
9/18/2024	Sell	3,871	$27.56	$106,684.76	75,294
9/16/2024	Sell	2,485	$27.52	$68,387.20	75,294
9/10/2024	Sell	637	$26.18	$16,676.66	75,294
8/26/2024	Sell	5,200	$27.51	$143,052.00	75,931
8/23/2024	Sell	8,851	$27.53	$243,668.03	75,931
6/11/2024	Sell	2,825	$22.64	$63,958.00	74,867
3/4/2024	Sell	20,646	$35.49	$732,726.54	78,415
12/14/2023	Sell	597	$20.76	$12,393.72	77,910
9/21/2023	Sell	5,000	$48.07	$240,350.00	46,010
9/13/2023	Sell	617	$50.34	$31,059.78	46,010
8/28/2023	Sell	5,745	$49.99	$287,192.55	46,627
6/23/2023	Sell	11,000	$50.76	$558,360.00	46,627
6/21/2023	Sell	11,349	$52.26	$593,098.74	68,627
1/13/2023	Sell	5,000	$50.53	$252,650.00	81,268
12/12/2022	Sell	5,000	$43.23	$216,150.00	86,268
11/10/2022	Sell	5,000	$39.42	$197,100.00	72,073
10/10/2022	Sell	5,000	$37.99	$189,950.00	77,073
9/13/2022	Sell	40,000	$27.48	$1,099,200.00	82,073
10/15/2021	Sell	12,500	$21.59	$269,875.00
8/16/2021	Sell	10,000	$18.79	$187,900.00	145,921
7/15/2021	Sell	10,000	$20.90	$209,000.00

Catriona Yale Buying and Selling Activity at Akero Therapeutics

Akero Therapeutics Company Overview

Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Today's Range

Now: $30.64

$29.88

$31.60

50 Day Range

MA: $29.73

$25.70

$35.28

2 Week Range

Now: $30.64

$15.32

$37.00

Volume

539,077 shs

Average Volume

866,979 shs

Market Capitalization

$2.14 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

Get Your Free Gold Guide

Catriona Yale Biography and Net Worth

What is Catriona Yale's net worth?

How old is Catriona Yale?

What is Catriona Yale's salary?

How do I contact Catriona Yale?

Has Catriona Yale been buying or selling shares of Akero Therapeutics?

Who are Akero Therapeutics' active insiders?

Are insiders buying or selling shares of Akero Therapeutics?

Catriona Yale Insider Trading History at Akero Therapeutics

Catriona Yale Buying and Selling Activity at Akero Therapeutics

Akero Therapeutics Company Overview

Today's Range

50 Day Range

2 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta